Skip to main content
Georgia Public Broadcasting Logo
  • Watch

    Featured Specials and Programs

    • All Creatures Great and Small
    • Antiques Roadshow
    • PBS News Hour
    • Miss Scarlet & The Duke
    • Finding Your Roots
    • Doc Martin
    All Programs

    GPB Originals

    • Georgia Legends
    • Lawmakers
    • A Fork in the Road
    • View Finders
    • Georgia Outdoors
    • Your Fantastic Mind
    GPB Originals

    Browse by Genre

    • Arts & Music
    • Culture
    • Drama
    • Food
    • History
    • News & Public Affairs
    • TV Schedule
    • GPB Programs
    • PBS Passport
    • TV Highlights this Week
    • PBS KIDS
    • Ways to Watch
    • Newsletters
    • Contact GPB
  • Listen

    Featured Programs

    • The Daily
    • Morning Edition
    • All Things Considered
    • Serendipity
    • John Lemley's City Cafe
    • Fresh Air
    • Here and Now
    • Code Switch/Life Kit
    • Wait Wait... Don't Tell Me!
    All Programs

    Podcasts

    • GA Today
    • Salvation South
    • Battleground: Ballot Box
    • Football Fridays in Georgia
    • Narrative Edge
    • Peach Jam Podcast
    • A Fork in the Road
    • Radio Schedule
    • GPB Classical
    • Radio Programs
    • Podcasts
    • GPB News
    • Find Your Station
    • Ways to Listen
    • Contact GPB
    • Newsletters
  • Learn

    Featured

    • Chemistry Matters
    • Classroom Conversations Podcast
    • GASHA Go! World
    • Georgia Farmcraft®
    • Georgia Classroom
    • Georgia Studies Collection
    • Econ Express
    • Let’s Go Enviro
    • Let's Learn GA!
    • Lights, Camera, Budget!
    • Live Explorations
    • Physics in Motion
    • School Stories
    • Virtual Field Trips
    • VR in the Classroom
    • Writers Contest

    For Kids & Teachers

    • GPB Games
    • PBS KIDS
    • PBS LearningMedia

    • on Twitter
    • on Facebook
    • on Email
  • News

    Featured Programs & Series

    • Lawmakers
    • Lawmakers: Beyond the Dome
    • 1A
    • Battleground: Ballot Box
    • GA Today Podcast
    • Storycorps
    • Narrative Edge

    More GPB News

    • Politics
    • Georgia News
    • Justice
    • Arts & Life
    • Health
    All GPB News
    • Radio Schedule
    • Radio Stations
    • GPB Apps
    • Podcasts
    • Contact GPB News
    • Follow Us on Apple News
    • Newsletters
  • Sports

    GHSA Sports

    • Football
    • Basketball
    • Cheerleading
    • On Demand
    • GPB Sports Blog
    All Sports

    High School Football

    • Scores & Schedule
    • On Demand
    • Teams
    • Rankings
    • Brackets
    • Heads Up Georgia
    Football Home
    • GPB Sports App
    • GPB Sports Blog
    • GPB Sports OnDemand
  • Events

    Browse by Type

    • Community
    • Donor
    • Kids & Family
    • Screenings
    All Events

    Browse by Category

    • Education
    • News
    • Sports
    • Television

    Sign up to receive GPB Event announcements via Email.

    Sign up

    • on Twitter
    • on Facebook
    • on Instagram
  • Kids & Families

    For Kids

    • Video
    • Games

    For Parents & Caregivers

    • Kids & Families Blog
    • Kids & Families Events
    • GPB KIDS - Ways to Watch
  • Support Us

    Support GPB

    • Ways to Give
    • Planned Giving
    • Sustainers
    • GPB Passport
    • Leadership Giving
    • Corporate Sponsorship
    • Vehicle Donations
    • GPB Next
    • Matching Gifts
  • Search
GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Listen Live Listen Live Watch Live Watch Live

GPB Newsletter CTA

Sign Up For Our Newsletter

News Topics

  • Georgia
  • National
  • Politics
  • Lawmakers
  • Elections

Don't Miss

Don't Miss:

  • New Podcast: Robbery, Inc
  • Federal Funding Update
  • Explore GPB Passport

News Articles: pfizer

A resident receives a dose of the Pfizer COVID-19 vaccine at a health center in Jakarta, Indonesia, on Jan. 13. This week, Indonesia started a program to give booster shots to the elderly and people at risk of severe disease.

Tagged as: 

  • Global Health

Booster longevity: Data reveals how long a third shot protects

Researchers in the U.K. have the first estimates for how long a third shot of the Pfizer vaccine will last. The findings are mixed.

January 20, 2022
|
By:
  • Michaeleen Doucleff
Pfizer's antiviral pill Paxlovid was authorized to treat COVID-19, by the Food and Drug Administration on Wednesday.

Tagged as: 

  • Health

FDA authorizes 1st antiviral pill for COVID

In a highly anticipated decision, the Food and Drug Administration authorized Pfizer's Paxlovid as the first antiviral pill to treat COVID-19 at home.

December 22, 2021
|
By:
  • Scott Hensley
Fever is a possible side effect of a COVID19 vaccine.

Tagged as: 

  • Global Health

Coronavirus FAQ: What does it mean if the booster knocks me out? What if it doesn't?

Vaccine and booster side effects can include fever, aches and fatigue. And this may be the first vaccine in history where people complain if they don't experience side effects, says one doctor.

December 10, 2021
|
By:
  • Sheila Mulrooney Eldred
Here's a computer-generated image of the omicron variant of the coronavirus — also known as B.1.1.529. Reported in South Africa on Nov. 24, this variant has a large number of mutations, some of which are concerning.

Tagged as: 

  • Global Health

Studies suggest sharp drop in vaccine protection vs. omicron — yet cause for optimism

In small studies in South Africa and in Germany, the results indicate a marked decrease in the ability of vaccines to neutralize this variant. But there are other findings that are encouraging.

December 08, 2021
|
By:
  • Michaeleen Doucleff
People line up outside a free COVID-19 vaccination site that opened Friday in Washington, D.C. The local health department is stepping up vaccination and booster shots as more cases of the omicron variant are being identified in the United States.

Tagged as: 

  • Health

Omicron boosters are in the works, but will they be needed?

Omicron has many more mutations than previous variants of concern, a fact that raises questions about how effective existing vaccines will be against the new form of the coronavirus.

December 07, 2021
|
By:
  • Sydney Lupkin
Scientists at Pfizer's research and development laboratories in Groton, Conn., worked on the COVID-19 pill called Paxlovid.

Tagged as: 

  • Health

How Pfizer developed a COVID pill in record time

Pfizer researchers looking for a drug to treat SARS found clues that gave the company a head start in its quest for a pill to treat COVID-19, including the omicron variant.

December 03, 2021
|
By:
  • Joe Palca
Keidy Ventura, 17, receives her first dose of the Pfizer COVID-19 vaccine in West New York, N.J. Pfizer has asked federal regulators to expand the eligibility for booster shots to include 16- and 17-year-olds.

Tagged as: 

  • Health

Pfizer wants the FDA to let 16- and 17- year-olds get a COVID-19 booster shot

Pfizer's CEO says the vaccine maker has asked federal regulators to authorize boosters for 16- and 17-year-olds. Currently, only people 18 and over are eligible for a booster in the U.S.

November 30, 2021
|
By:
  • Will Stone
Molnupiravir, an antiviral drug to treat mild to moderate COVID-19, is under consideration by an FDA advisory panel for possible authorization.

Tagged as: 

  • Health

New antiviral drugs are coming for COVID. Here's what you need to know

The FDA is considering new pills that could treat people in early stages of COVID. Here's what to know about how they work, how effective they are and the impact they could make on the pandemic.

November 30, 2021
|
By:
  • Pien Huang
Nurse Sandra Lindsay celebrates after receiving her COVID-19 Pfizer vaccine booster at Long Island Jewish Medical Center in New York in October. Lindsay was the first person known to receive a COVID vaccine in the United States vaccination campaign — on Dec. 14, 2020. Her vaccination card is displayed at the COVID-19 exhibit in the Smithsonian Museum of American History.

Tagged as: 

  • Global Health

Coronavirus FAQ: I just got a booster. Can I ... go crazy?

Does a booster shot mean that you can go back to ... normal? Or is there still a newish kind of normal to face?

November 13, 2021
|
By:
  • Sheila Mulrooney Eldred
Safeway pharmacist Shahrzad Khoobyari administers a Pfizer-BioNTech COVID-19 booster shot to Chen Knifsend at a vaccination clinic in San Rafael, Calif., in October. The companies are seeking regulatory authorization to expand boosters to everyone 18 and older.

Tagged as: 

  • Health

Pfizer and BioNTech ask FDA to authorize COVID vaccine booster for people 18+

The companies say a study of more than 10,000 volunteers showed a vaccine efficacy of 95% or greater for people receiving the booster.

November 09, 2021
|
By:
  • Joe Palca
Containers of Moderna COVID-19 vaccine doses, donated by the United States, arrive in Bogota, Colombia, in July. The U.S. plans to send more than a billion vaccines abroad by September 2022.

Tagged as: 

  • Global Health

What the U.S. can — and cannot — do for vaccine equity per the State Department

The U.S. has pledged to deliver 1.1 billion doses of COVID vaccines to countries in need. Billions more are needed. NPR interviewed the State Department's global vaccine coordinator to learn more.

October 25, 2021
|
By:
  • NPR Staff
Pharmacist LaChandra McGowan prepares a dose of the Pfizer COVID-19 vaccine at a clinic operated by DePaul Community Health in New Orleans in August. Soon, children ages 5 to 11 could be eligible for Pfizer shots.

Tagged as: 

  • Health

Pfizer-BioNTech COVID vaccine appears more than 90% effective in kids 5 to 11

The companies studied a 10 microgram vaccine dose in children 5 to 11, a third of the dose used for adults, to minimize side effects and because it still prompts a strong immune response.

October 22, 2021
|
By:
  • Scott Hensley
A healthcare worker prepares doses of the Pfizer-BioNTech Covid-19 vaccine at a mobile vaccination clinic at a high school in Los Angeles in August.

Tagged as: 

  • Health

Pfizer officially asks the FDA to authorize its COVID vaccine for kids aged 5-11

"With new cases in children in the U.S. continuing to be at a high level, this submission is an important step in our ongoing effort against #COVID19," the pharmaceutical giant said.

October 07, 2021
|
By:
  • Joe Hernandez
Medics in Jerusalem transfer a COVID-19 patient to Hadassah Hospital Ein Kerem. Many hospitals in Israel are at full capacity following a sharp increase in coronavirus infections.

Tagged as: 

  • Global Health

Highly Vaccinated Israel Is Seeing A Dramatic Surge In New COVID Cases. Here's Why

What happened? Here are six lessons learned from Israel's experience — and one looming question for the future of the pandemic.

August 20, 2021
|
By:
  • Daniel Estrin
The Biden administration reportedly will recommend Americans get booster shots eight months after they've been fully vaccinated against COVID-19.

Tagged as: 

  • Health

The Biden Administration May Recommend COVID Boosters After 8 Months

A source familiar with the discussions says administration health experts could make the recommendation for fully vaccinated adults as soon as this week.

August 17, 2021
|
By:
  • Barbara Campbell and
  • Jaclyn Diaz
  • Load More

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News

Footer

Footer First Nav (Main Menu)

  • Watch
  • Listen
  • Learn
  • News
  • Sports
  • Events
  • Kids & Families
  • Support Us
  • Search

Footer Second Nav Menu

  • Help Center
  • About GPB
  • Contact Us
  • Closed Captioning
  • Directions
  • Studio Production
  • Program Submissions

Footer Third Nav Menu

  • Support Us
  • Careers
  • Accessibility
  • FCC Public Files
  • Drawing Rules
  • News Media Request
  • Open Records and Document Retention Policy
  • Privacy Policy

Georgia Public Broadcasting

260 14th St. NW
Atlanta, GA 30318
United States

(404) 685-2400 In Atlanta
(800) 222-4788 Outside Atlanta
ask@gpb.org

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News
© Copyright 2025, Georgia Public Broadcasting. All Rights Reserved. Georgia Public Radio® GPTV®